These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice. Davignon JL; Cohen PL; Eisenberg RA J Immunol; 1988 Sep; 141(6):1848-54. PubMed ID: 3262641 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807 [TBL] [Abstract][Full Text] [Related]
4. A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line. Higgs JB; Zeldes W; Kozarsky K; Schteingart M; Kan L; Bohlke P; Krieger K; Davis W; Fox DA J Immunol; 1988 Jun; 140(11):3758-65. PubMed ID: 2836500 [TBL] [Abstract][Full Text] [Related]
5. In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody. Ferran C; Bluestone J; Bach JF; Chatenoud L Transplant Proc; 1990 Aug; 22(4):1922-3. PubMed ID: 2143865 [No Abstract] [Full Text] [Related]
6. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. Pescovitz MD; Lunney JK; Sachs DH J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627 [TBL] [Abstract][Full Text] [Related]
10. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens. Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262 [TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization. Salgar SK; Paape MJ; Alston-Mills B Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127 [TBL] [Abstract][Full Text] [Related]
12. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies. Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932 [TBL] [Abstract][Full Text] [Related]
13. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells. Wassmer P; Chan C; Lögdberg L; Shevach EM J Immunol; 1985 Oct; 135(4):2237-42. PubMed ID: 3897371 [TBL] [Abstract][Full Text] [Related]
14. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody. Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473 [TBL] [Abstract][Full Text] [Related]
15. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes. Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200 [TBL] [Abstract][Full Text] [Related]
16. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes. Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881 [TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013 [TBL] [Abstract][Full Text] [Related]